- 101. MAFOSFAMIDE
- [A form of cyclophosphamide that can be administered as an intrathecal infusion. Mafosfamide is being studied as an anticancer drug. It belongs to the family of drugs called alkylating agents. ( NCI )] (UMLS (NCI) C0065506) =Organophosphorus Compound; Pharmacologic Substance ;
| - 151. Magnetic resonance spectroscopy
- [Magnetic resonance spectroscopic imaging. A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). ( NCI )] (UMLS (HL7) C0024487) =Diagnostic Procedure ;
=Modality;
|
- 102. MAG (myelin associated glycoprotein)
- [family of heavily glycosylated, NCAM-like membrane proteins that serve to glue the extracellular faces of myelin lamellae in tight apposition; transient expression may control the spiral wrapping of the myelin sheath around an axon. ( CSP )] (UMLS (CSP) C0129439) =Amino Acid, Peptide, or Protein; Neuroreactive Substance or Biogenic Amine ;
=glycoprotein;
nerve/myelin protein | - 152. magnetic therapy
- [ ] (UMLS (CSP) C0872210) =Therapeutic or Preventive Procedure ;
|
- 103. magainin
- [A class of antimicrobial peptides discovered in the skin of XENOPUS LAEVIS. They kill bacteria by permeabilizing cell membranes without exhibiting significant toxicity against mammalian cells. ( MSH )] (UMLS (CSP) C0597875) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 153. magnetoencephalography
- [measurement of magnetic activity of the brain, usually conducted externally by sensitive devices such as SQUID's; electric currents generated in the brain by neural activity are accompanied by orthogonal magnetic fields and the measurement of these fields provide information about the localization of brain activity which is complementary to that provided by electroencephalography. ( CSP )] (UMLS (CSP) C0024489) =Diagnostic Procedure ;
=encephalography;
biomagnetism measurement |
- 104. MAGE-1 Antigen
- [A cancer specific antigen expressed by the melanoma antigen gene. ( NCI )] (UMLS (NCI) C0126758) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 154. magnetometry
- [ ] (UMLS (CSP) C0024490) =Occupational Activity ;
|
- 105. MAGE-10.A2
- [A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response against tumor cells that express the melanoma-associated antigen, resulting in tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C1134715) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 155. Magnifier
- [An optical device that enlarges the apparent size of an image or object. ( NCI )] (UMLS (NCI) C0445078) =Medical Device ;
|
- 106. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Sargramostim/tyrosinase peptide
- (UMLS (NCI) C1134658) =Therapeutic or Preventive Procedure
| - 156. Magnocellular Nevus
- [A benign melanocytic proliferation within or adjacent to the optic disk. It presents as a pigmented, intraocular tumor. ( NCI )] (UMLS (NCI) C0334431) =Neoplastic Process
|
- 107. MAGE-10.A2/Melan-A/NY-ESO-1 peptide vaccine/Tyrosinase peptide
- (UMLS (NCI) C1134657) =Therapeutic or Preventive Procedure
| - 157. MAGUK Family Gene
- [Membrane-Associated Guanylate Kinase Family Genes encode MAGUK (Membrane-Associated GUanylate Kinase homolog) proteins containing DHR, SH3, and C-terminal GK-like domains. MAGUKs include Drosophila lethal(1)discs large-1 tumor suppressor protein (dlg1); mammalian Zo-1 tight junction protein; mammalian synaptic proteins that seem to interact with the cytoplasmic tail of NMDA receptor subunits (SAP90/PSD-95, CHAPSYN-110/PSD-93, SAP97/DLG1 and SAP102); 55 kD erythrocyte membrane protein (p55); C. elegans lin-2 protein; rat CASK protein; and human DLG2 and DLG3 proteins. An N-terminal ATP-binding site (P-loop) of Guanylate Kinase is not conserved in the MAGUK GK-like domain; MAGUKs do retain residues known in GK to bind GMP. (NCI) ( NCI )] (UMLS (NCI) C1334692) Membrane-Associated Guanylate Kinase Family Gene;
=Gene or Genome |
- 108. MAGE-12 Peptide Vaccine
- [A synthetic vaccine comprised of a peptide consisting of peptide fragments of melanoma-associated antigen 12 (MAGE-12). MAGE-12 has been identified as an epitope recognized by tumor infiltrating lymphocytes (TIL). Vaccination with MAGE-12 peptide stimulates the host immune system to mount a TIL response against tumor cells expressing MAGE-12, potentially resulting in decreased tumor growth. ( NCI )] (UMLS (NCI) C0935670) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 158. Mahayana
- (UMLS (HL7) C1552051) =Idea or Concept =Religious Affiliation;
|
- 109. MAGE-12 peptide vaccine/Montanide ISA-51
- (UMLS (NCI) C0935671) =Therapeutic or Preventive Procedure
| - 159. MAI Lymphadenitis
- (UMLS (NCI) C0858196) Mycobacterium Avium Intracellulare Lymphadenitis =Disease or Syndrome
|
- 110. MAGE-3
- [Expressed only in normal testis and placenta by human MAGEA3 Gene, MAGE-3.1 Antigen has an unknown function. (NCI) ( NCI )] (UMLS (NCI) C0962473) MAGE-3 Antigen;
MAGE-3.1 Antigen;
MAGEA3;
=Amino Acid, Peptide, or Protein; Immunologic Factor ;
| - 160. Maiden
- [A woman's surname before marriage. ( NCI )] (UMLS (NCI) C0806887) Maiden Name;
=Intellectual Product ;
=Name type;
|
- 111. MAGE-3
- [A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04) ( NCI )] (UMLS (NCI) C1510427) MAGE-3.1;
Recombinant MAGE-3.1 Antigen =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 161. MAIDS
- [mouse model of AIDS. ( CSP )] (UMLS (NCI) C0079864) =Experimental Model of Disease =Retroviridae disease;
Tumor Virus Infections;
acquired immunodeficiency;
|
- 112. MAGE-3.1/PADRE 965.10
- (UMLS (NCI) C0879247) MAGE-3/PADRE 965.10;
=Therapeutic or Preventive Procedure | - 162. Maiduan
- (UMLS (HL7) C1699746) =Language ;
=Penutian;
=Mountain Maidu;
Concow;
Neeshenam;
|
- 113. MAGE-3/SB AS-2
- (UMLS (NCI) C0879284) =Therapeutic or Preventive Procedure
| - 163. Mail
- (UMLS (HL7) C1547565) =Idea or Concept =Authorization Mode;
|
- 114. MAGE12
- [This gene may be involved in carcinogenesis. ( NCI )] (UMLS (NCI) C1416973) MAGEA12 Gene;
Melanoma Antigen Family A, 12 Gene =Gene or Genome ◊ [Expressed only in normal testis by human MAGEA12 Gene (MAGE Family), 314-aa 35-kDa MAGE-12 Antigen is a tumor-specific antigen of unknown function recognized by autologous cytolytic T lymphocytes and containing a MAGE domain. (NCI) ( NCI )] (UMLS (NCI) C1449389) MAGE-12 Antigen; MAGEA12; Melanoma Antigen Family A 12; Amino Acid, Peptide, or Protein; Immunologic Factor | - 164. Mail Claim Party
- (UMLS (HL7) C1550412) =Classification =HL7 Vocabulary Version 2.5;
=Employer;
Guarantor;
Insurance Company;
Other;
Patient |
- 115. MAGEA3
- [This gene may be involved in embryonal development. It may also play a role in carcinogenesis. ( NCI )] (UMLS (NCI) C0677907) =Gene or Genome ;
| - 165. Mailing
- (UMLS (HL7) C1549634) =Idea or Concept =Address type;
|
- 116. MAGED1
- [Encoded by MAGED1 Gene (MAGE Family), ubiquitous 778-amino acid 86-kD cytoplasmic NRAGE Protein contains a 200-amino acid MAGE homology domain. NRAGE appears to shift from cytoplasm to plasma membrane upon NGF stimulation to interact with p75NTR. NRAGE antagonizes p75NTR association with TRKA, inhibits cell cycle progression, and facilitates p75NTR-mediated apoptosis. NRAGE may regulate the function of DLX family members. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0960824) MAGE-D1 Antigen;
Melanoma-Associated Antigen D1;
NRAGE Protein;
PRO2292;
Urotrophin Receptor-Interacting MAGE Homolog Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 166. Mailto
- [Electronic mail address [RFC 2368]http://www.ietf.org/rfc/rfc2368.txt . ( HL7V3.0 )] (UMLS (HL7) C1555014) =Idea or Concept =URLScheme;
|
- 117. MAGED1
- [This gene is a member of the melanoma antigen gene family and facilitates cell death. ( NCI )] (UMLS (NCI) C1334472) MAGED1 Gene;
Melanoma Antigen Family D, 1 Gene =Gene or Genome | - 167. Main Bronchus
- (UMLS (NCI) C0024496) =Body Part, Organ, or Organ Component ;
|
- 118. maggot
- [ ] (UMLS (CSP) C0016386) =Invertebrate
| - 168. Maine
- [A state in the northeastern United States. Its capital is Augusta. ( NCI )] (UMLS (NCI) C0024497) =Geographic Area ;
|
- 119. Magnesium
- [A measurement of the magnesium in a biological specimen. ( NCI )] (UMLS (NCI) C0373675) =Laboratory Procedure
| - 169. mainframe computer
- [a large, fast computer whose capacity will support multiple, simultaneous users and applications; it is the largest type of computer. ( CSP )] (UMLS (CSP) C0009626) =Manufactured Object ;
=computer hardware;
|
- 120. Magnesium Acetate Tetrahydrate
- [The hydrated acetate salt form of magnesium. Magnesium is a divalent cation essential for a number of biochemical processes involved in nerve signaling, bone mineralization and muscle contractions. About 350 enzymes involved in glycolysis and the Krebs cycle, formation of cyclic-AMP and ATP, cellular signal transduction and protein and nucleic acid synthesis are dependent on magnesium. ( NCI )] (UMLS (NCI) C0991847) MAGNESIUM ACETATE TETRAHYDRATE PREPARATION;
=Organic Chemical; Pharmacologic Substance ;
=Unclassified Ingredients;
Inactive Ingredient Preparations =MAGNESIUM ACETATE TETRAHYDRATE 32 MG/100ML;
MAGNESIUM ACETATE TETRAHYDRATE 54 MG | - 170. Maintain
- [The act of sustaining something in its current form or proper condition; upkeep. ( NCI )] (UMLS (NCI) C0024501) =Activity ;
|
- 121. MAGNESIUM CARBONATE
- (UMLS (NCI) C0065517) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
[PH000] PHARMACEUTICAL AIDS / REAGENTS =ASA 500MG/CA CARB/MG CARB/MG OXIDE TAB;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CORN STARCH/METHYLBENZETHONIUM CL 0.055% PWDR,TOP;
MAGNESIUM CARBONATE BLOCKS;
QUINAPRIL 10 MG / QUINAPRIL HYDROCHLORIDE ORAL TABLET, FILM COATED;
quinapril 20 MG Oral Tablet;
quinapril 5 MG Oral Tablet;
QUINAPRIL 40 MG ORAL TABLET;
MAGNESIUM CARBONATE 260 MG;
MAGNESIUM CARBONATE 137.3 MG/5ML;
MAGNESIUM CARBONATE 400 MG;
MAGNESIUM CARBONATE 400 MG/5ML;
MAGNESIUM CARBONATE 97 MG;
MAGNESIUM CARBONATE 105 MG;
MAGNESIUM CARBONATE 232 MG;
MAGNESIUM CARBONATE 350 MG/5ML;
MAGNESIUM CARBONATE 300 MG;
MAGNESIUM CARBONATE 200 MG;
MAGNESIUM CARBONATE 57 MG;
MAGNESIUM CARBONATE 34 MG;
MAGNESIUM CARBONATE 160 MG;
MAGNESIUM CARBONATE 130 MG;
MAGNESIUM CARBONATE 100 MG;
MAGNESIUM CARBONATE 120 MG;
MAGNESIUM CARBONATE 238 MG/5ML;
MAGNESIUM CARBONATE 137.5 MG/5ML;
MAGNESIUM CARBONATE 3.177 GM/100ML;
MAGNESIUM CARBONATE 41.7 MG | - 171. maintained entity
- [An entity (player) that is maintained by another entity (scoper). This is typical role held by durable equipment. The scoper assumes responsibility for proper operation, quality, and safety. ( HL7V3.0 )] (UMLS (HL7) C1550599) =Idea or Concept =RoleClassPassive;
|
- 122. MAGNESIUM CHLORIDE
- [Magnesium Chloride was used as a laxative. An alkaline earth metal, magnesium is important for many biochemical functions and reactions; for bone and muscle function, protein and fatty acid formation, activation of B vitamins, blood clotting, insulin secretion, and ATP formation. More than 300 enzymes require magnesium for catalytic action. The adult daily requirement is about 300 mg/day. Magnesium is found in many green plants, vegetables, and seeds; chlorophyll is a magnesium-centered porphyrin compound. Magnesium salts are used for magnesium deficiency supplementation. (NCI04) ( NCI )] (UMLS (NCI) C0024472) =Pharmacologic More…
| - 172. maintenance therapy
- [Treatment that is given to help a primary (original) treatment keep working. Maintenance therapy is often given to help keep cancer in remission. ( NCI )] (UMLS (NCI) C0677908) =Therapeutic or Preventive Procedure ;
|
- 123. MAGNESIUM CLOFIBRATE
- (UMLS (NCI) C0771940) =Organic Chemical; Pharmacologic Substance ;
| - 173. maize chlorotic dwarf virus
- [ ] (UMLS (CSP) C0599363) =Virus ;
|
- 124. magnesium deficiency
- [condition due to decreased dietary intake of magnesium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss; deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior. ( CSP )] (UMLS (CSP) C0024473) =Disease or Syndrome ;
=Deficiency Diseases;
dietary deficiency;
metal metabolism disorder;
| - 174. maize rough dwarf virus
- [ ] (UMLS (CSP) C0599311) =Virus ;
|
- 125. MAGNESIUM HYDROXIDE
- [A solution of magnesium hydroxide with antacid and laxative properties. Milk of magnesium exerts its antacid activity in low doses such that all hydroxide ions that enter the stomach are used to neutralize stomach acid. This agent exerts its laxative effect in higher doses so that hydroxide ions are able to move from the stomach to the intestines where they attract and retain water, thereby increasing intestinal movement (peristalsis) and inducing the urge to defecate. ( NCI )] (UMLS (NCI) C0024476) =Pharmacologic Substance; Inorganic Chemical =Hydroxides;
[TN406] MAGNESIUM;
Magnesium Compounds;
[GA202] HYPEROSMOTIC LAXATIVES;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=magaldrate;
aluminum magnesium hydroxide;
AL OH 150MG/ASA 325MG/MG OH 150MG TAB;
CASCARA/MAGNESIUM HYDROXIDE CONC SUSP;
NEPRO LIQUID VANILLA;
MAGNESIUM HYDROXIDE 160 MG;
MAGNESIUM HYDROXIDE 200 MG;
MAGNESIUM HYDROXIDE 300 MG;
MAGNESIUM HYDROXIDE 311 MG;
MAGNESIUM HYDROXIDE 200 MG/5ML;
MAGNESIUM HYDROXIDE 400 MG;
MAGNESIUM HYDROXIDE 300 MG/5ML;
MAGNESIUM HYDROXIDE 75 MG;
MAGNESIUM HYDROXIDE 80 MG;
MAGNESIUM HYDROXIDE 400 MG/5ML;
MAGNESIUM HYDROXIDE 103 MG/5ML;
MAGNESIUM HYDROXIDE 325 MG;
MAGNESIUM HYDROXIDE 165 MG;
MAGNESIUM HYDROXIDE 50 MG;
MAGNESIUM HYDROXIDE 450 MG/5ML;
MAGNESIUM HYDROXIDE 225 MG/5ML;
Magnesium Hydroxide 16 MG/ML;
MAGNESIUM HYDROXIDE 130 MG;
MAGNESIUM HYDROXIDE 5 MG;
MAGNESIUM HYDROXIDE 450 MG/ML;
MAGNESIUM HYDROXIDE 128 MG;
MAGNESIUM HYDROXIDE 100 MG;
Magnesium Hydroxide 120 MG/ML;
MAGNESIUM HYDROXIDE 1200 MG/5ML;
MAGNESIUM HYDROXIDE 350-425 MG/5ML;
| - 175. Major
- [Greater or bigger in amount, extent, or size. ( NCI )] (UMLS (NCI) C0205164) =Qualitative Concept
|
- 126. magnesium ion
- [divalent cation of magnesium essential in nutrition. ( CSP )] (UMLS (CSP) C0596876) =Biologically Active Substance; Element, Ion, or Isotope =ion;
| - 176. Major abnormality of bony pelvis, not further specified, antepartum
- [ ] (UMLS (ICD9CM) C0156968) =Acquired Abnormality; Disease or Syndrome
|
- 127. MAGNESIUM TRISILICATE
- (UMLS (NCI) C0065533) =Pharmacologic Substance; Inorganic Chemical ;
=[TN406] MAGNESIUM;
Magnesium Silicates;
[GA108] MAGNESIUM CONTAINING ANTACIDS;
=MAGNESIUM TRISILICATE 20 MG;
magnesium trisilicate 250 MG;
MAGNESIUM TRISILICATE 400 MG/5ML;
MAGNESIUM TRISILICATE 455 MG;
MAGNESIUM TRISILICATE 40 MG;
| - 177. Major abnormality of bony pelvis, not further specified, delivered
- [ ] (UMLS (ICD9CM) C0156967) =Acquired Abnormality; Disease or Syndrome
|
- 128. MAGNET REMOV ANT SEG FB
- [ ] (UMLS (ICD9CM) C0197593) =Therapeutic or Preventive Procedure
| - 178. Major abnormality of bony pelvis, not further specified, in pregnancy, labor, and delivery
- [ ] (UMLS (ICD9CM) C0269713) =Anatomical Abnormality
|
- 129. MAGNET REMOV POST SEG FB
- [ ] (UMLS (ICD9CM) C0197806) =Therapeutic or Preventive Procedure
| - 179. Major abnormality of bony pelvis, not further specified, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156966) =Acquired Abnormality; Disease or Syndrome
|
- 130. MAGNET REMOVAL CORNEA FB
- [ ] (UMLS (ICD9CM) C0844519) Magnetic removal of embedded foreign body from cornea =Therapeutic or Preventive Procedure
| - 180. Major anomalies of jaw size
- (UMLS (ICD9CM) C0024508) =Congenital Abnormality ;
|
- 131. MAGNET REMOVE FB LENS
- [ ] (UMLS (ICD9CM) C0197743) =Therapeutic or Preventive Procedure
| - 181. major depression
- [one or more periods of depression in the absence of history of manic or hypomanic episodes; chronic type lasts 2 or more years; melancholic type is more severe, has vegetative signs, and responds well to somatic therapy. ( CSP )] (UMLS (CSP) C1269683) =Mental or Behavioral Dysfunction =clinical depression;
PSYCHOSES |
- 132. magnetic
- [processes and behaviors associated with magnetic fields. ( CSP )] (UMLS (CSP) C0563532) =Natural Phenomenon or Process =Physical Phenomenon;
=magnetic field;
biomagnetism;
| - 182. Major Depression
- [A mood disorder having a clinical course involving one or more episodes of serious psychological depression that last two or more weeks each, do not have intervening episodes of mania or hypomania, and are characterized by a loss of interest or pleasure in almost all activities and by some or all of disturbances of appetite, sleep, or psychomotor functioning, a decrease in energy, difficulties in thinking or making decisions, loss of self-esteem or feelings of guilt, and suicidal thoughts or attempts. ( NCI )] (UMLS (NCI) C0041696) =Mental or Behavioral Dysfunction
|
- 133. magnetic beads
- [ ] (UMLS (CSP) C1328924) =Natural Phenomenon or Process; ;
| - 183. Major depressive disorder, recurrent episode
- [ ] (UMLS (ICD9CM) C0154409) =Mental or Behavioral Dysfunction
|
- 134. magnetic colloid
- [ ] (UMLS (CSP) C0598192) =Biomedical or Dental Material
| - 184. Major depressive disorder, recurrent episode, in full remission
- [ ] (UMLS (ICD9CM) C0154415) =Mental or Behavioral Dysfunction
|
- 135. magnetic field
- [portion of space near a magnetic body or a current-carrying body in which the magnetic forces due to the body or current can be detected. ( CSP )] (UMLS (CSP) C0563533) =Natural Phenomenon or Process =magnetic;
=TMS | - 185. Major depressive disorder, recurrent episode, in partial or unspecified remission
- [ ] (UMLS (ICD9CM) C0338893) =Mental or Behavioral Dysfunction
|
- 136. Magnetic flux
- (UMLS (HL7) C1547031) =Quantitative Concept =Kind of quantity;
| - 186. Major depressive disorder, recurrent episode, mild degree
- [ ] (UMLS (ICD9CM) C0154410) =Mental or Behavioral Dysfunction
|
- 137. magnetic recording system
- [ ] (UMLS (CSP) C0596877) =Intellectual Product ;
=biomedical automation;
| - 187. Major depressive disorder, recurrent episode, moderate degree
- [ ] (UMLS (ICD9CM) C0154411) =Mental or Behavioral Dysfunction
|
- 138. MAGNETIC RES IMAGE UNSP
- (UMLS (ICD9CM) C0024486) =Diagnostic Procedure ;
| - 188. Major depressive disorder, recurrent episode, severe degree, specified as with psychotic behavior
- [ ] (UMLS (ICD9CM) C0154413) =Mental or Behavioral Dysfunction
|
- 139. Magnetic resonance
- [Computed, Magnetic resonance ( HL7V3.0 )] (UMLS (HL7) C1551403) =Laboratory Procedure =ObservationMethod;
| - 189. Major depressive disorder, recurrent episode, severe degree, without mention of psychotic behavior
- [ ] (UMLS (ICD9CM) C0154412) =Mental or Behavioral Dysfunction
|
- 140. Magnetic Resonance
- [A physical phenomenon involving the interaction of atomic nuclei placed in an external magnetic field with an applied electromagnetic field oscillating at a particular frequency. Magnetic conditions within the material are measured by monitoring the radiation absorbed and emitted by the atomic nuclei. It is the underlying principle of Magnetic Resonance Imaging (MRI). ( NCI )] (UMLS (NCI) C0028580) =Natural Phenomenon or Process ;
| - 190. Major Diagnostic Category
- (UMLS (HL7) C1550395) =Classification =HL7 Vocabulary Version 2.5;
|
- 141. Magnetic resonance angiography
- [Non-invasive method of vascular imaging and determination of internal anatomy without injection of contrast media or radiation exposure. The technique is used especially in CEREBRAL ANGIOGRAPHY as well as for studies of other vascular structures. ( MSH )] (UMLS (HL7) C0243032) =Diagnostic Procedure ;
=Modality;
| - 191. major histocompatibility complex
- [genetic region found in all mammals whose products are primarily reponsible for the rapid rejection of grafts between individuals and which signal between lymphocytes and cells expressing antigen; H-2 in mouse and HLA in humans. ( CSP )] (UMLS (CSP) C0024518) =Gene or Genome ;
=histocompatibility gene;
|
- 142. Magnetic Resonance Imaging
- (UMLS (HL7) C1552358) =Professional or Occupational Group =Radiologic Technologist;
| - 192. Major Histocompatibility Complex Gene
- [A group of linked loci, collectively termed H-2 complex in the mouse and HLA complex in humans, that codes for cell-surface histocompatibility antigens and is the principal determinant of tissue type and transplant compatibility. ( NCI )] (UMLS (NCI) C1334545) =Gene or Genome
|
- 143. magnetic resonance imaging
- [non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images; concept includes proton spin tomographic techniques. ( CSP )] (UMLS (NCI) C0024485) =Diagnostic Procedure ;
=imaging/visualization/scanning;
nuclear magnetic resonance spectroscopy =fMRI;
diffusion magnetic resonance imaging;
| - 193. Major Histocompatibility Complex Receptor
- [immunoglobulin like receptor associated with CD3 marker on T lymphocytes which binds specific antigen and thereby participates in T cell activation; recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen receptor structure, composed of either alpha-beta or gamma-delta chains. ( CSP )] (UMLS (NCI) C0034790) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =antigen receptor;
|
- 144. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1552430) =Intellectual Product ;
=Clinic/Center;
| - 194. Major Late Transcription Factor 1
- [Ubiquitously expressed by human USF1 Gene, 310-aa 34-kDa nuclear Upstream Stimulatory Factor 1 is a bHLH transcription factor that binds to symmetrical E-box DNA (CACGTG) in viral and cellular promoters as a homodimer or USF1/USF2 heterodimer (USF). Efficient DNA binding requires dimerization with another bHLH protein and USF1 can act synergistically with GTF2I to activate transcription. Direct GTF2I interaction requires the USF1 activation and dimerization domains. USF1/USF2A heterodimer represents most USF binding activity. (NCI) ( NCI )] (UMLS (NCI) C1451716) Upstream Stimulatory Factor 1;
USF1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 145. Magnetic Resonance Imaging (MRI)
- (UMLS (HL7) C1555766) =Intellectual Product =Internal Medicine;
| - 195. Major medical
- (UMLS (HL7) C1549486) =Idea or Concept =Policy type;
|
- 146. Magnetic resonance imaging of brain and brain stem
- [ ] (UMLS (ICD9CM) C0412675) =Diagnostic Procedure
| - 196. Major Operative
- (UMLS (HL7) C1547206) =Idea or Concept =Procedure DRG Type;
|
- 147. Magnetic resonance imaging of chest and myocardium
- [ ] (UMLS (ICD9CM) C0202827) =Diagnostic Procedure
| - 197. MAJOR OSSEOUS DEFECTS
- [ ] (UMLS (ICD9CM) C1719624) =Disease or Syndrome
|
- 148. Magnetic resonance imaging of musculoskeletal structures
- (UMLS (ICD9CM) C0202673) =Diagnostic Procedure
| - 198. MAJOR PUERP INF-DEL P/P
- [ ] (UMLS (ICD9CM) C0157491) =Disease or Syndrome ;
|
- 149. Magnetic resonance imaging of pelvis, prostate, and bladder
- [ ] (UMLS (ICD9CM) C0203122) =Diagnostic Procedure
| - 199. MAJOR PUERP INF-POSTPART
- [ ] (UMLS (ICD9CM) C0375477) =Disease or Syndrome
|
- 150. Magnetic resonance imaging of spinal canal
- [ ] (UMLS (ICD9CM) C0177803) =Diagnostic Procedure
| - 200. MAJOR PUERP INFECT-UNSP
- [ ] (UMLS (ICD9CM) C0375476) =Disease or Syndrome
|
home
